ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,376 | +49.3% | 485,202 | +43.1% | 0.06% | +74.3% |
| Q2 2023 | $4,272 | -34.4% | 339,064 | -32.0% | 0.04% | -35.2% |
| Q1 2023 | $6,511 | +783.4% | 498,919 | +1094.3% | 0.05% | +390.9% |
| Q4 2022 | $737 | -99.9% | 41,776 | -28.6% | 0.01% | -8.3% |
| Q3 2022 | $891,000 | -22.3% | 58,484 | -24.3% | 0.01% | -14.3% |
| Q2 2022 | $1,146,000 | -65.8% | 77,291 | -48.1% | 0.01% | -66.7% |
| Q1 2022 | $3,353,000 | +111.8% | 148,873 | +73.5% | 0.04% | +162.5% |
| Q4 2021 | $1,583,000 | -49.3% | 85,806 | -63.3% | 0.02% | -61.9% |
| Q3 2021 | $3,123,000 | +101.4% | 233,563 | +126.1% | 0.04% | +82.6% |
| Q1 2021 | $1,551,000 | -54.7% | 103,305 | -56.4% | 0.02% | -30.3% |
| Q4 2020 | $3,423,000 | +613.1% | 236,858 | +301.8% | 0.03% | +230.0% |
| Q3 2020 | $480,000 | +42.9% | 58,946 | +18.7% | 0.01% | +11.1% |
| Q2 2020 | $336,000 | -53.8% | 49,654 | -33.0% | 0.01% | -35.7% |
| Q4 2019 | $727,000 | – | 74,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
| KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
| Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
| Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
| Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
| S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
| HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
| BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |